EMBERA NEUROTHERAPEUTICS
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.
EMBERA NEUROTHERAPEUTICS
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2005-01-01
Address:
Sudbury, Massachusetts, United States
Country:
United States
Website Url:
http://www.emberaneuro.com
Total Employee:
11+
Status:
Active
Contact:
+1 (318) 213-0198
Total Funding:
28.41 M USD
Technology used in webpage:
IPv6 Google Maps Google Maps API Cloudflare Hosting Cloudflare DNS Intermedia
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Innovation Catalyst
Innovation Catalyst investment in Series A - Embera NeuroTherapeutics
Rose Research Center (RRC) in North Carolina
Rose Research Center (RRC) in North Carolina investment in Grant - Embera NeuroTherapeutics
Keiretsu Capital
Keiretsu Capital investment in Series B - Embera NeuroTherapeutics
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) investment in Grant - Embera NeuroTherapeutics
Keiretsu Capital
Keiretsu Capital investment in Venture Round - Embera NeuroTherapeutics
National Institutes of Health
National Institutes of Health investment in Grant - Embera NeuroTherapeutics
Keiretsu Capital
Keiretsu Capital investment in Grant - Embera NeuroTherapeutics
Keiretsu Capital
Keiretsu Capital investment in Venture Round - Embera NeuroTherapeutics
Keiretsu Capital
Keiretsu Capital investment in Venture Round - Embera NeuroTherapeutics
HRA Pharma
HRA Pharma investment in Series A - Embera NeuroTherapeutics
Official Site Inspections
http://www.emberaneuro.com Semrush global rank: 5.85 M Semrush visits lastest month: 1.42 K
- Host name: 104.21.25.122
- IP address: 104.21.25.122
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Embera NeuroTherapeutics"
Management Team - Embera Neuro
Mr. Connor leads the Embera organization as its Chief Operating Officer in addition to his clinical operations responsibilities, after serving as consulting Director of Clinical Operations at …See details»
Embera NeuroTherapeutics Announces Successful …
— Embera to Present at the Biotech Showcase in January 2016 — BOSTON, Mass. and SHREVEPORT, La.—January 6, 2016—Embera NeuroTherapeutics, Inc., a specialty …See details»
Embera NeuroTherapeutics - LinkedIn
Embera NeuroTherapeutics | 341 followers on LinkedIn. Embera NeuroTherapeutics is a clinical stage pharmaceutical company developing novel treatments for to potentially treat a range of addictions ...See details»
Meet Embera NeuroTherapeutics’ CEO, Bob Linke, and …
Jul 17, 2018 As a result, a likely scenario with positive phase 2 data will be that Embera will license or sell its products to a pharmaceutical company who is seeking to bolster their late …See details»
Embera NeuroTherapeutics - Crunchbase …
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no …See details»
Embera NeuroTherapeutics CEO and Key Executive Team
Embera NeuroTherapeutics's Executive Chairman, Director is Robert B. Linke. Other executives include John B. Beaird, Director; Gary Connor, Vice President, Clinical Operations and 6 …See details»
Embera NeuroTherapeutics Completes Series B Financing …
Dec 19, 2019 Company Contact Bob Linke President and CEO [email protected] 617-719-9406 Media Contact Kari Watson MacDougall [email protected] 781-235-3060 …See details»
Board of Directors - Embera Neuro
Mr. Linke has 30 years of diversified healthcare experience in pharma/biopharmaceutical, medical device, diagnostic, and healthcare informatics markets.See details»
Embera NeuroTherapeutics - Craft
Embera NeuroTherapeutics $27.14 m in total funding,. See insights on Embera NeuroTherapeutics including office locations, competitors, revenue, financials, executives, …See details»
Embera NeuroTherapeutics Announces First Subject Dosed in
Jun 30, 2021 www.emberaneuro.com Note: The EMB-001 cocaine use disorder clinical research discussed in this press release was supported by the National Institute on Drug Abuse of the …See details»
Embera NeuroTherapeutics to Present at the 2017 BIO …
Oct 13, 2017 Embera NeuroTherapeutics, Inc. Bob Linke, 617-719-9406 President and CEO [email protected] or For Media: MacDougall Biomedical Communications Kari …See details»
Embera NeuroTherapeutics, Inc. Initiates Phase 1 Clinical …
May 28, 2015 BOSTON & SHREVEPORT, La.--(BUSINESS WIRE)--Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for …See details»
Development Advisory Board – Embera Neuro
Prior to Satori, Dr. Ives held numerous senior management and scientific leadership positions at Pfizer. Dr. Ives led the CNS and pain research teams at Pfizer for over two decades and, from …See details»
Home - EmbarkNeuro
OUR BIOLOGY. In contrast to standard antidepressants, our technology is designed to address disruptions in the stress response system seen in many patients with depression, especially …See details»
Embera NeuroTherapeutics Inc. - BioCentury Company …
Oct 20, 2022 Embera NeuroTherapeutics Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Embera NeuroTherapeutics Careers - Levels.fyi
Embera NeuroTherapeutics is a US-based company that focuses on researching and developing addiction pharmaceuticals. They specialize in creating treatments that target specific brain …See details»
Science Advisory Board – Embera Neuro
Dr. Kathleen T. Brady is a board-certified psychiatrist specializing in addiction psychiatry. As a Professor of Psychiatry at the Medical University of South Carolina, Dr. Brady is Director of the …See details»
Embera NeuroTherapeutics, Inc. (Embera …
EMB-001 is a combination of 2 drugs: the cortisol synthesis inhibitor, metyrapone (Metopirone®), and the benzodiazepine receptor agonist, oxazepam (original trade name Serax®; now …See details»
Pipeline - Embera Neuro
Jun 3, 2016 Embera’s Combination Treatment: EMB-001. EMB-001 is a patented combination product comprised of two FDA-approved medications, the cortisol synthesis inhibitor …See details»